BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17645376)

  • 1. Dermatologic manifestations of polycystic ovary syndrome.
    Lee AT; Zane LT
    Am J Clin Dermatol; 2007; 8(4):201-19. PubMed ID: 17645376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations.
    Housman E; Reynolds RV
    J Am Acad Dermatol; 2014 Nov; 71(5):847.e1-847.e10; quiz 857-8. PubMed ID: 25437977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovary syndrome: a dermatologic approach.
    Moura HH; Costa DL; Bagatin E; Sodré CT; Manela-Azulay M
    An Bras Dermatol; 2011; 86(1):111-9. PubMed ID: 21437531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients.
    Hong JS; Kwon HH; Park SY; Jung JY; Yoon JY; Min S; Choi YM; Suh DH
    J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):42-7. PubMed ID: 24628922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
    Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
    JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
    J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome and acne.
    Chuan SS; Chang RJ
    Skin Therapy Lett; 2010; 15(10):1-4. PubMed ID: 21076799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatology of androgen-related disorders.
    Essah PA; Wickham EP; Nunley JR; Nestler JE
    Clin Dermatol; 2006; 24(4):289-98. PubMed ID: 16828411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatologic manifestation of hyperandrogenism: a retrospective chart review.
    Clark CM; Rudolph J; Gerber DA; Glick S; Shalita AR; Lowenstein EJ
    Skinmed; 2014; 12(2):84-8. PubMed ID: 24933845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome.
    Lowenstein EJ
    Dermatol Ther; 2006; 19(4):210-23. PubMed ID: 17004997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polycystic ovary syndrome and hair unit function disturbances in dermatological practice].
    Szpringer EA; Lutnicki KR; Zych IS
    Wiad Lek; 2006; 59(11-12):848-54. PubMed ID: 17427503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acne - a potential skin marker of internal disease.
    Pace JL
    Clin Dermatol; 2015; 33(5):572-8. PubMed ID: 26321405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism.
    Ozdemir S; Ozdemir M; Görkemli H; Kiyici A; Bodur S
    Acta Obstet Gynecol Scand; 2010; 89(2):199-204. PubMed ID: 19900078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous Manifestations of Polycystic Ovary Syndrome: A Cross-Sectional Clinical Study.
    Keen MA; Shah IH; Sheikh G
    Indian Dermatol Online J; 2017; 8(2):104-110. PubMed ID: 28405549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acne-associated syndromes: models for better understanding of acne pathogenesis.
    Chen W; Obermayer-Pietsch B; Hong JB; Melnik BC; Yamasaki O; Dessinioti C; Ju Q; Liakou AI; Al-Khuzaei S; Katsambas A; Ring J; Zouboulis CC
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):637-46. PubMed ID: 21198949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome.
    Azziz R; Carmina E; Chen Z; Dunaif A; Laven JS; Legro RS; Lizneva D; Natterson-Horowtiz B; Teede HJ; Yildiz BO
    Nat Rev Dis Primers; 2016 Aug; 2():16057. PubMed ID: 27510637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts of polycystic ovary syndrome.
    Rosenfield RL
    Baillieres Clin Obstet Gynaecol; 1997 Jun; 11(2):307-33. PubMed ID: 9536213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acne severity and the Global Acne Grading System in polycystic ovary syndrome.
    Hacivelioglu S; Gungor AN; Gencer M; Uysal A; Hizli D; Koc E; Cosar E
    Int J Gynaecol Obstet; 2013 Oct; 123(1):33-6. PubMed ID: 23948280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen excess: Investigations and management.
    Lizneva D; Gavrilova-Jordan L; Walker W; Azziz R
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():98-118. PubMed ID: 27387253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatologic manifestations of endocrine disorders.
    Quatrano NA; Loechner KJ
    Curr Opin Pediatr; 2012 Aug; 24(4):487-93. PubMed ID: 22781138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.